Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome
The aim of this study was to evaluate the safety and immunogenicity of the BNT162b2 vaccine in young people with
January 28, 2022
The aim of this study was to evaluate the safety and immunogenicity of the BNT162b2 vaccine in young people with
The T21RS COVID-19 Initiative launched an international survey to obtain information on safety and efficacy of COVID-19 vaccines for individuals
Findings from a recent study of the largest documented cohort of individuals with Down syndrome (DS) in the United States
Findings from a recent study describing prevalence of common disease conditions in the largest documented cohort of individuals with Down
The work shows the cellular and humoral responses to SARS-CoV-2 vaccination of 36 individuals with Down syndrome (DS) after one
A recent disease prevalence study of the largest documented Down syndrome (DS) cohort in the United States strongly suggested significant
This document addresses the education settings that support students with Down syndrome, covering the period from early intervention and primary
Adults with Down syndrome (DS) are at higher risk for severe outcomes of coronavirus disease 2019 (COVID-19) then the general
This resource shares tips for communicating with patients with intellectual disabilities. As the tips indicate, the most important thing to
Objectives: To derive and validate risk prediction algorithms to estimate the risk of COVID-19 related mortality and hospital admission in